Boston Scientific's (BSX) Precision Montage MRI SCS allows patients to undergo a full-body 1.5 Tesla MRI scan while also delivering multiple waveforms.

Boston Scientific has received the CE Mark for the Precision Plus Spinal Cord Stimulator System, a rechargeable SCS device. The system provides peripheral nerve stimulation for patients with chronic ...

Boston Scientific Corporation’s BSX successful result from its WHISPER randomized controlled trial (RCT) further boosts its neuromodulation business. This announcement follows the recent FDA approval ...

Shares of Boston Scientific Corp. rose 1.7% in premarket trade Thursday, after the company said the U.S. Food and Drug Administration has approved its Spectra WaveWriter spinal cord simulator ...

MARLBOROUGH, Mass., Sept. 30, 2020 /PRNewswire/ -- Boston Scientific (NYSE: BSX) today announced the European launch of the WaveWriter Alpha™ portfolio of Spinal Cord Stimulator (SCS) Systems ...

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Spectra WaveWriter™ Spinal Cord Stimulator (SCS) System in Europe.

Boston Scientific Corporation BSX recently announced the receipt of the FDA’s approval for its WaveWriter Alpha portfolio of Spinal Cord Stimulator (“SCS”) Systems. The U.S. commercial ...

Interestingly, Boston Scientific's Precision Montage MRI SCS allows patients to undergo a full-body 1.5 Tesla MRI scan while also delivering multiple waveforms.

Boston Scientific Corporation BSX recently announced the receipt of the FDA’s approval for its WaveWriter Alpha portfolio of Spinal Cord Stimulator (“SCS”) Systems. The U.S. commercial ...

Boston Scientific Corporation BSX recently announced the receipt of the FDA’s approval for its WaveWriter Alpha portfolio of Spinal Cord Stimulator (“SCS”) Systems. The U.S. commercial launch of the ...